TKNO

Alpha Teknova, Inc. [TKNO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

TKNO Stock Summary

Top 10 Correlated Stocks

TKNO


In the News

04:01 22 Feb 2024 TKNO

Teknova to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

HOLLISTER, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2023, on Monday, March 11, 2024, following the close of market.

05:01 22 Feb 2024 TKNO

Alpha Teknova, Inc. (TKNO) Q3 2023 Earnings Call Transcript

Alpha Teknova, Inc. (TKNO) Q3 2023 Earnings Call Transcript

08:00 22 Feb 2024 TKNO

Teknova to Report Third Quarter 2023 Financial Results on November 9, 2023

Teknova today announced that the Company will report its financial results for the third quarter on Thursday, November 9, 2023, following close of market.

09:20 22 Feb 2024 TKNO

Alpha Teknova, Inc. (TKNO) Q2 2023 Earnings Call Transcript

Alpha Teknova, Inc. (NASDAQ:TKNO ) Q2 2023 Earnings Conference Call August 10, 2023 5:30 PM ET Company Participants Sara Michelmore - MacDougall Advisors Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Chief Financial Officer Conference Call Participants Steven Mah - TD Cowen Matt Larew - William. Blair Paul Knight - KeyBanc Mark Massaro - BTIG Jacob Johnson - Stephens Operator Good day, and welcome to Teknova's Second Quarter 2023 Financial Results Conference Call.

08:00 22 Feb 2024 TKNO

Teknova to Report Second Quarter 2023 Financial Results on August 10, 2023

HOLLISTER, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the second quarter ended June 30, 2023, on Thursday, August 10, 2023, following the close of market.

08:00 22 Feb 2024 TKNO

Teknova to Participate in Upcoming Investor Conference

HOLLISTER, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will present and host individual and small group meetings at the following upcoming investor conference:

01:57 22 Feb 2024 TKNO

Alpha Teknova, Inc. (TKNO) Q1 2023 Earnings Call Transcript

Alpha Teknova, Inc. (NASDAQ:TKNO ) Q1 2023 Earnings Conference Call May 10, 2023 5:30 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Chief Financial Officer Conference Call Participants Jacob Johnson - Stephens Madeline Mollman - William Blair Steven Mah - TD Cowen Operator Good day, and welcome to the Teknova First Quarter 2023 Financial Results Call. [Operator Instructions] Please be advised that today's conference is being recorded.

08:00 22 Feb 2024 TKNO

Teknova to Present Data on Novel Products to Accelerate the Development of AAV Therapies at ASGCT 2023 Annual Meeting

Company will share their latest findings for custom product innovations aimed at addressing key gene therapy bioprocessing bottlenecks Company will share their latest findings for custom product innovations aimed at addressing key gene therapy bioprocessing bottlenecks

08:00 22 Feb 2024 TKNO

Teknova to Report First Quarter 2023 Financial Results on May 10, 2023

HOLLISTER, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the first quarter ended March 31, 2023, on Wednesday, May 10, 2023, following the close of market.

10:42 22 Feb 2024 TKNO

Down -48.43% in 4 Weeks, Here's Why You Should You Buy the Dip in Alpha Teknova (TKNO)

Alpha Teknova (TKNO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

TKNO Financial details

Company Rating
Neutral
Market Cap
128.7M
Income
-39.42M
Revenue
36.71M
Book val./share
3.33
Cash/share
1.07
Dividend
-
Dividend %
-
Employees
285
Optionable
No
Shortable
Yes
Earnings
20 Mar 2024
P/E
-2.9
Forward P/E
-6.14
PEG
-0.23
P/S
4.23
P/B
1.15
P/C
2.81
P/FCF
-4.27
Quick Ratio
4.47
Current Ratio
6.13
Debt / Equity
0.31
LT Debt / Equity
0.29
-
-
EPS (TTM)
-1.37
EPS next Y
-0.49
EPS next Q
1.58
EPS this Y
177.05%
EPS next Y
-64.23%
EPS next 5Y
-64.23%
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-29.13%
EPS Q/Q
36%
-
-
-
-
SMA20
-
SMA50
-
SMA100
50%
Inst Own
10.02%
Inst Trans
0.63%
ROA
-28%
ROE
-42%
ROC
-0.27%
Gross Margin
30%
Oper. Margin
-95%
Profit Margin
-107%
Payout
-
Shs Outstand
40.73M
Shs Float
10.31M
-
-
-
-
Target Price
-
52W Range
1.62-5.91
52W High
-39.8%
52W Low
+201%
RSI
45
Rel Volume
0.1
Avg Volume
26.57K
Volume
2.53K
Perf Week
-5.05%
Perf Month
-13.51%
Perf Quarter
54.36%
Perf Half Y
23.87%
-
-
-
-
Beta
0.307
-
-
Volatility
0.06%, 0.2%
Prev Close
0.33%
Price
3.01
Change
-3.53%

TKNO Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K
Revenue per share
0.961.482.291.47
Net income per share
-0.060.17-0.61-1.69
Operating cash flow per share
0.10.12-0.56-0.98
Free cash flow per share
-0.02-0.14-1.8-1.98
Cash per share
0.460.245.441.5
Book value per share
0.610.798.93.56
Tangible book value per share
-1.17-0.936.712.93
Share holders equity per share
0.610.798.93.56
Interest debt per share
000.71.51
Market cap
525.89M527.8M329.48M158.39M
Enterprise value
521.79M524.48M253.83M158.47M
P/E ratio
-402.98147.84-33.61-3.34
Price to sales ratio
26.1716.868.933.82
POCF ratio
242.12210.7-36.33-5.78
PFCF ratio
-1.1K-178.25-11.38-2.85
P/B Ratio
40.7431.482.31.59
PTB ratio
40.7431.482.31.59
EV to sales
25.9716.766.883.83
Enterprise value over EBITDA
-2.24K78.2-27.82-32.39
EV to operating cash flow
240.24209.37-27.99-5.78
EV to free cash flow
-1.09K-177.13-8.77-2.85
Earnings yield
00.01-0.03-0.3
Free cash flow yield
0-0.01-0.09-0.35
Debt to equity
000.080.42
Debt to assets
000.070.28
Net debt to EBITDA
17.59-0.498.29-0.02
Current ratio
2.764.1413.075.62
Interest coverage
0020.39-135.48
Income quality
-1.660.70.930.58
Dividend Yield
0000
Payout ratio
0000
Sales general and administrative to revenue
0.380.260.550.68
Research and developement to revenue
0.040.050.120.19
Intangibles to total assets
0.640.580.210.12
Capex to operating cash flow
-1.22-2.182.191.03
Capex to revenue
-0.13-0.17-0.54-0.68
Capex to depreciation
-1.63-2.67-6.89-8.89
Stock based compensation to revenue
00.010.040.09
Graham number
0.931.7411.0511.63
ROIC
-0.10.21-0.06-0.17
Return on tangible assets
-0.060.13-0.07-0.35
Graham Net
-1.54-1.624.43-0.03
Working capital
9.84M12.45M93.46M50.27M
Tangible asset value
-24.7M-19.7M107.89M82.33M
Net current asset value
-30.18M-29.73M77.9M8.76M
Invested capital
000.080.42
Average receivables
04.78M6.21M5.07M
Average payables
01.2M1.94M2.35M
Average inventory
03.07M4.49M8.82M
Days sales outstanding
54.2476.6157.9237.74
Days payables outstanding
24.3344.0742.5837.33
Days of inventory on hand
81.396.55102.16186.69
Receivables turnover
6.734.766.39.67
Payables turnover
158.288.579.78
Inventory turnover
4.493.783.571.96
ROE
-0.10.21-0.07-0.48
Capex per share
-0.13-0.26-1.24-1

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.380.280.320.410.27
Net income per share
-0.8-0.47-0.31-0.25-0.34
Operating cash flow per share
-0.3-0.29-0.27-0.14-0.15
Free cash flow per share
-0.53-0.45-0.43-0.22-0.18
Cash per share
1.771.51.070.841.07
Book value per share
3.993.553.273.053.33
Tangible book value per share
3.352.922.652.452.77
Share holders equity per share
3.993.553.273.053.33
Interest debt per share
1.281.511.461.411
Market cap
93.82M158.79M83.42M75.49M83.58M
Enterprise value
79.93M158.86M94.12M92.01M82.31M
P/E ratio
-1.04-2.99-2.37-2.64-2.06
Price to sales ratio
8.7720.129.156.5510.23
POCF ratio
-11.26-19.78-10.86-19.58-19.07
PFCF ratio
-6.29-12.45-6.95-12.19-15.61
P/B Ratio
0.841.590.910.880.84
PTB ratio
0.841.590.910.880.84
EV to sales
7.4820.1310.327.9810.08
Enterprise value over EBITDA
7.27-31.98-12.04-70.24-9.39
EV to operating cash flow
-9.59-19.79-12.25-23.86-18.78
EV to free cash flow
-5.36-12.45-7.85-14.86-15.37
Earnings yield
-0.24-0.08-0.11-0.09-0.12
Free cash flow yield
-0.16-0.08-0.14-0.08-0.06
Debt to equity
0.320.420.440.470.31
Debt to assets
0.220.280.290.30.22
Net debt to EBITDA
-1.26-0.01-1.37-12.610.14
Current ratio
5.685.625.741.56.13
Interest coverage
146.74-78.5-96.1922.7211.08
Income quality
0.370.60.870.540.43
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.610.940.810.520.75
Research and developement to revenue
0.180.240.150.130.17
Intangibles to total assets
0.110.120.120.130.12
Capex to operating cash flow
0.790.590.560.610.22
Capex to revenue
-0.62-0.6-0.47-0.2-0.12
Capex to depreciation
-9.03-5.3-3.82-1.8-0.6
Stock based compensation to revenue
0.090.130.110.090.13
Graham number
8.476.144.84.175.04
ROIC
0.06-0.06-0.06-0.05-0.06
Return on tangible assets
-0.16-0.1-0.07-0.06-0.08
Graham Net
0.41-0.03-0.32-0.440.1
Working capital
57.74M50.27M40.98M14.46M42.74M
Tangible asset value
94.15M82.33M74.82M69.23M82.96M
Net current asset value
21.79M8.76M697K-3.23M12.35M
Invested capital
0.320.420.440.470.31
Average receivables
6.15M5.33M4.54M5.22M5.4M
Average payables
2.45M2.97M2.17M1.48M1.25M
Average inventory
9.12M11.29M12.2M12.08M11.74M
Days sales outstanding
53.648.8547.3544.0756.85
Days payables outstanding
52.9638.1325.3315.0619.11
Days of inventory on hand
156.88190.66163.27167.41154.12
Receivables turnover
1.681.841.92.041.58
Payables turnover
1.72.363.555.984.71
Inventory turnover
0.570.470.550.540.58
ROE
-0.2-0.13-0.1-0.08-0.1
Capex per share
-0.23-0.17-0.15-0.08-0.03

TKNO Frequently Asked Questions

What is Alpha Teknova, Inc. stock symbol ?

Alpha Teknova, Inc. is a US stock , located in Hollister of Ca and trading under the symbol TKNO

What is Alpha Teknova, Inc. stock quote today ?

Alpha Teknova, Inc. stock price is $3.01 today.

Is Alpha Teknova, Inc. stock public?

Yes, Alpha Teknova, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Top Correlated Stocks
Similar Market Cap